tirzepatide action mechanism The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity tirzepatide.pptx

Diabetes Care 2011;34(7):14811486

It's important to note that Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) are FDA-approved for chronic weight management, while Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved for type 2 diabetes management, though sometimes used off-label for weight loss

Tirzepatide works by addressing these root causes, which is why many patients see changes in their midsection as their metabolic health improves

This is where dangerous mistakes happen if you are not paying attention

Zofran blocks these 5-HT3 receptors, preventing serotonin from binding to them

Tirzepatide (Mounjaro/Zepbound) has more site flexibility than semaglutide